万托林雾化吸入治疗小儿咳嗽变异性哮喘临床疗效分析

Efficacy Observation of Atomized Inhalation of Ventolin for Treating Child Cough Variant Asthma

目的观察万托林联合布地奈德,采用压力泵雾化吸入治疗咳嗽变异性哮喘(cva)的临床疗效。方法将本院近两年来106例咳嗽变异性哮喘患儿随机分成两组,治疗组53例,对照组53例,对照组给予布地奈德雾化吸入治疗,疗程4周。治疗组在此基础上加用万托林雾化吸入治疗,疗程4周。结果治疗组咳嗽明显缓解时间和咳嗽消失时间均短于对照组,患儿经过1个月治疗,对照组53例,总有效率为75.47%;观察组53例,总有效率为94.34%。两组比较,差异有统计学意义(P<0.05),两组具有可比性。结论万托林能够有效改善儿童咳嗽变异性哮喘的咳嗽等症状,值得临床推广应用。

ObjectiveTo observe Ventolin budesonide inhalation using pressure pumps clinical efficacy of treatment of cough variant asthma（cva） ＇s.Methods hospital the past two years 106 cases of children with cough variant asthma were randomly divided into two groups, the treatment group 53 cases, 53 cases in the control group, the control group received budesonide inhalation therapy, 4 weeks. Treatment group based on the use Ventolin inhalation therapy, 4 weeks.Results In the treatment group significantly alleviate cough cough disappeared time and times are shorter than the control group after one month treatment of children in the control group 53 cases, total effective rate was 75.47%; 53 cases in the observation group, the total effective rate was 94.34% . Two groups, the difference was statistically significant （P〈0.05）, the two groups were comparable.Conclusion Ventolin can improve children＇s cough variant asthma symptoms such as cough, worthy of clinical application.